ArticleBMC research notes2026
In vitro assessment of the impact of di(2-ethylhexyl) phthalate and its metabolites on the function and transcription of key glucose sensing proteins in a rat pancreatic β-cell line.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDi(2-ethylhexyl) phthalate (DEHP) is a plasticizer used in everyday products, making human exposure unavoidable. DEHP exposure has been associated with disruptions in insulin secretion. This study assessed the in vitro effects of DEHP and its metabolites, mono(2-ethylhexyl) phthalate (MEHP) and mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), on the function and transcription of glucose transporter 2 (GLUT2) and glucokinase in RIN-5 F pancreatic β-cells. Cells were exposed to various chemical concentrations; glucose uptake, glucokinase activity and gene expression were assessed.
resultsShort-term exposure to DEHP and MEHP disrupted glucose uptake at normal glucose, however, the effects were not evident at high glucose or following the 24-hour exposure period. Glucokinase activity was not significantly altered by the treatments. Preliminary gene expression analysis after 24-hour chemical exposure indicated upregulation of GLUT2 transcription while MEHP additionally enhanced glucokinase gene expression, without corresponding alterations at a functional level. The findings suggest that DEHP and its metabolites modulate the function and transcription of key proteins in the pancreatic β-cells glucose sensing system. This highlights the importance of assessing DEHP exposure effects on processes upstream of insulin secretion in β-cells. The study provides a basis for future investigations incorporating quantitative PCR, protein expression and GLUT2 localization to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.